Joseph Papa

Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ.

Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. The company was founded in 1887 and is headquartered in Allegan, MI.

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Bausch & Lomb Holdings, Inc. developed, manufactured, and sold eye health products. Its products included contact lenses, contact lens care solutions, ophthalmic pharmaceuticals, and surgical products. The company was founded on September 25, 2009 and was headquartered in Rochester, NY.

DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.

G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985.

Sergeant's Pet Care Products, Inc. manufactures pet supplies. It offers flea and tick remedies, health and well-being products, natural and formulated treats, rawhide chews, toys, accessories, dental and aquatics. The company was founded in 1868 and is headquartered in Omaha, NE.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

Perrigo Florida, Inc. manufactures private label health and personal care products. Its offers pediatric electrolyte solutions and personal care products. The company was founded on May 8, 1992 and is headquartered in Lake Worth, FL.

Actavis Pharma, Inc. develops, manufactures, and markets pharmaceutical products. It offers solid dosage and sterile dosage generic products. The company is headquartered in Morristown, NJ.

Water Street Healthcare Partners LLC (Water Street Healthcare Partners) is a private equity firm founded in 2005. The firm is headquartered in Chicago, Illinois.

Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark.

SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.

Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation.

Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .

Beyeonics Surgical Ltd. is a medical technology company based in Haifa, Israel. The Israeli company, along with its sister company Beyeonics Vision, develops and delivers digital surgical platforms to operating rooms across multiple therapeutic areas. Beyeonics Surgical focuses on orthopedic surgical platforms and has pipeline applications that include minimally invasive surgery utilizing VR and AR-based navigation and data processing. The company was founded by Avi Zeitouny and Ron Schneider, with Ron Schneider serving as CEO since incorporation.